Literature DB >> 19584860

Targeting lymphotoxin depletes pathogenic T cells.

Anna M Hansen1, Rachel R Caspi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19584860      PMCID： PMC2757749          DOI： 10.1038/nm0709-732

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  7 in total

Review 1.  The molecular basis of T helper 1 and T helper 2 cell differentiation.

Authors:  A O'Garra; N Arai
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

2.  Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data.

Authors:  A R Abbas; D Baldwin; Y Ma; W Ouyang; A Gurney; F Martin; S Fong; M van Lookeren Campagne; P Godowski; P M Williams; A C Chan; H F Clark
Journal:  Genes Immun       Date:  2005-06       Impact factor: 2.676

Review 3.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 4.  Regulatory T cells and immune tolerance.

Authors:  Shimon Sakaguchi; Tomoyuki Yamaguchi; Takashi Nomura; Masahiro Ono
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

5.  Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease.

Authors:  Eugene Y Chiang; Ganesh A Kolumam; Xin Yu; Michelle Francesco; Sinisa Ivelja; Ivan Peng; Peter Gribling; Jean Shu; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Andres Paler-Martinez; Allen Nguyen; Judy Young; Kai H Barck; Richard A D Carano; Ron Ferrando; Lauri Diehl; Devavani Chatterjea; Jane L Grogan
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

Review 6.  Mechanisms of foxp3+ T regulatory cell-mediated suppression.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

Review 7.  Immunotherapy of autoimmunity and cancer: the penalty for success.

Authors:  Rachel R Caspi
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106
  7 in total
  1 in total

1.  The silent progression of metastatic malignancy during the treatment with soluble tumor necrosis factor receptor.

Authors:  Inhye E Ahn; Ji Hyeon Ju; Kwi Young Kang; Sung-Hwan Park; Ho-Youn Kim
Journal:  Clin Rheumatol       Date:  2009-11-07       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.